Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Furiex Pharmaceuticals Company Profile (NASDAQ:FURX)

Consensus Ratings for Furiex Pharmaceuticals (NASDAQ:FURX) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $147.00 (40.31% upside)

Analysts' Ratings History for Furiex Pharmaceuticals (NASDAQ:FURX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/5/2014Cowen and CompanyBoost Price Target$157.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2014Ladenburg ThalmannBoost Price TargetBuy$57.00 -> $137.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2013Cowen and CompanyLower Price TargetOutperform$54.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Canaccord GenuityBoost Price Target$47.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
5/30/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Ladenburg ThalmannBoost Price Target$38.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Canaccord GenuityReiterated RatingBuy$45.00 -> $47.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Ladenburg ThalmannBoost Price TargetBuy$33.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013Canaccord GenuityInitiated CoverageBuy$45.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)